CRISPR-based gene editing shows promise in treating rare form of blindness

FHS
May 6, 2024
6:43 pm

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.

Study explores link between prostate cancer treatment and Alzheimer’s disease

Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men with prostate cancer end

August 29, 2024

D.A. Wallach on his wife’s tragic death and creating a ‘golden record’ for medicine

D.A. Wallach met his late wife, Liz, at a Halloween party in Los Angeles hosted by the Maroon 5 star Adam Levine. At the time,

October 18, 2024

Researchers seek answers as they spell out Phase 3 failure of Bayer’s next-gen anticoagulant

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.